June 2002 —
Biotechnology is at the heart of a fast-growing new sector of the U.S. economy, and as the industry expands, it has become a focal point of many local, regional, and state economic development strategies. This report provides an analysis of biotechnology activity in the 51 largest U.S. metropolitan areas and finds that the industry is heavily concentrated in nine regions. These nine areas excel because they possess two key ingredients necessary for biotech growth: strong research, and the ability to convert that research into commercial activity. By comparing the 51 metro areas on their research and commercialization capacities, this report can help inform regions seeking to capture a share of the nation's biotechnology growth.
Related Content
Research and Commentary
Joseph Cortright and Heike Mayer, The Brookings Institution, January 2001
Research and Commentary
Howard Wial, The Brookings Institution, February 2007
Research and Commentary
Deena Heg, The Brookings Institution, October 2003
More Related Content »